Your browser doesn't support javascript.
loading
One-year follow-up of clinical, metabolic and oxidative stress profile of morbid obese patients after laparoscopic sleeve gastrectomy. 8-oxo-dG as a clinical marker.
Monzo-Beltran, Lidia; Vazquez-Tarragón, Antonio; Cerdà, Concha; Garcia-Perez, Paula; Iradi, Antonio; Sánchez, Carlos; Climent, Benjamin; Tormos, Carmen; Vázquez-Prado, Antonio; Girbés, Javier; Estáñ, Nuria; Blesa, Sebastián; Cortés, Raquel; Chaves, Felipe J; Sáez, Guillermo T.
Afiliação
  • Monzo-Beltran L; Dept. of Biochemistry and Molecular Biology, Faculty of Medicine and Odontology-INCLIVA, University of Valencia, Spain. Electronic address: Lidia.monzo@gmail.com.
  • Vazquez-Tarragón A; Service of General and Digestive Surgery, University Hospital Dr. Peset, Valencia, Spain. Electronic address: Tonivaz79@hotmail.com.
  • Cerdà C; Service of Clinical Analysis, General University Hospital, Valencia, Spain. Electronic address: Concermi@gmail.com.
  • Garcia-Perez P; Dept. of Biochemistry and Molecular Biology, Faculty of Medicine and Odontology-INCLIVA, University of Valencia, Spain. Electronic address: Paulagperez88@gmail.com.
  • Iradi A; Dept. of Physiology, Faculty of Medicine and Odontology, University of Valencia, Spain. Electronic address: Antonio.Iradi@uv.es.
  • Sánchez C; Endocrinology and Nutrition Unit, General University Hospital, Valencia, Spain. Electronic address: Carlos.sanchez@uv.es.
  • Climent B; Service of Internal Medicine, General University Hospital, Valencia, Spain. Electronic address: Climent_ben@gva.es.
  • Tormos C; Dept. of Biochemistry and Molecular Biology, Faculty of Medicine and Odontology-INCLIVA, University of Valencia, Spain. Electronic address: M.Carmen.Tormos@uv.es.
  • Vázquez-Prado A; Service of General and Digestive Surgery, General University Hospital, Valencia, Spain. Electronic address: Vprado.a@gmail.com.
  • Girbés J; Service of Clinical Analysis, University Hospital Dr. Peset, Valencia, Spain. Electronic address: Jagirllo88@gmail.com.
  • Estáñ N; Service of Clinical Analysis, University Hospital Dr. Peset, Valencia, Spain. Electronic address: Estany_nur@gva.es.
  • Blesa S; Genomic and Genetic Diagnosis Unit, INCLIVA, CIBEREDEM University of Valencia, Spain. Electronic address: Sebastian.blesa@uv.es.
  • Cortés R; Genomic and Genetic Diagnosis Unit, INCLIVA, CIBEREDEM University of Valencia, Spain. Electronic address: Raquel.Cortes@uv.es.
  • Chaves FJ; Genomic and Genetic Diagnosis Unit, INCLIVA, CIBEREDEM University of Valencia, Spain. Electronic address: Felipe.Chaves@uv.es.
  • Sáez GT; Dept. of Biochemistry and Molecular Biology, Faculty of Medicine and Odontology-INCLIVA, University of Valencia, Spain; Service of Clinical Analysis, University Hospital Dr. Peset, Valencia, Spain. Electronic address: Guillermo.saez@uv.es.
Redox Biol ; 12: 389-402, 2017 08.
Article em En | MEDLINE | ID: mdl-28319890
ABSTRACT
Obesity has grown worldwide over the last few decades. In its different degrees, obesity is accompanied by many clinical and biochemical alterations reflecting the pathological condition of various body tissues. Among the mechanisms underlying the pathogenesis of obesity and associated complications, oxidative stress (OS) may be playing an important role. In the present study, we have characterized at systemic level the degree of OS status in a group of morbid obese patients (BMI>40kg/m2) at basal sate and its modulation during one year after bariatric surgery using the laparoscopic sleeve gastrectomy (LSG) technique. As compared with normal weight subjects matched in age, peripheral blood mononuclear cells (PBMc) of obese patients present a significant reduction of the antioxidant enzyme activities superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx) as well as a significant increase of the oxidized/reduced glutathione ratio (GSSG/GSH) in these cells. Lipid peroxidation is significantly increased in the patient group as shown by the increased levels of malondialdehyde (MDA) in PBMc and the amount of F2-Isoprostanes (F2-IsoPs) released in urine. In addition, the DNA damage product 8-oxo-7,8-2'-deoxyguanosine (8-oxo-dG) was also observed to be increased in serum and urine of morbid obese patients as compared with the control group. After LSG, an improvement of their ponderal and metabolic profile was accompanied by a progressive recovery of antioxidant enzyme activities and the decline of oxidative byproducts both in PBMc and biological fluids. The observed changes of urinary 8-oxo-dG levels correlate positively with its serum concentration, the lipid peroxidation products MDA and F2-IsoPs, triglycerides, glucose, insulin, HOMA index and body weight and negatively with the percentage of weight and BMI loss and antioxidant activities. We conclude that the analysis of urinary 8-oxo-dG could be validated as a useful marker for the monitoring of ponderal and metabolic status of morbid obese patients.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Obesidade Mórbida / Biomarcadores / Desoxiguanosina Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Redox Biol Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Obesidade Mórbida / Biomarcadores / Desoxiguanosina Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Redox Biol Ano de publicação: 2017 Tipo de documento: Article